This is a phase 1 trial.
All the P2 'successes' that were commercialised without a P3 were pulled from the market years later.
The last 'event' like that was 2018.
The CEO (KK) and you are deluded if you think the GVHD trial will commercialise on the P2 alone.
Anyway. Back to reality. This is a phase 1 trial. Try and pay attention.
Ann: DFU Clinical Trial Enrolment Complete, page-14
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $52.99M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 29.5¢ | 27.5¢ | $29.94K | 106.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 10159 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CYP (ASX) Chart |